Free Trial

Sabra Healthcare REIT (SBRA) Competitors

Sabra Healthcare REIT logo
$21.10 +0.13 (+0.62%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$21.26 +0.15 (+0.73%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SBRA vs. CTRE, LTC, NHI, OHI, and WY

Should you buy Sabra Healthcare REIT stock or one of its competitors? MarketBeat compares Sabra Healthcare REIT with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sabra Healthcare REIT include CareTrust REIT (CTRE), LTC Properties (LTC), National Health Investors (NHI), Omega Healthcare Investors (OHI), and Weyerhaeuser (WY).

How does Sabra Healthcare REIT compare to CareTrust REIT?

Sabra Healthcare REIT (NASDAQ:SBRA) and CareTrust REIT (NYSE:CTRE) are both mid-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

Sabra Healthcare REIT has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market. Comparatively, CareTrust REIT has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

In the previous week, CareTrust REIT had 9 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 17 mentions for CareTrust REIT and 8 mentions for Sabra Healthcare REIT. Sabra Healthcare REIT's average media sentiment score of 0.97 beat CareTrust REIT's score of 0.75 indicating that Sabra Healthcare REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
CareTrust REIT
9 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 87.8% of CareTrust REIT shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by insiders. Comparatively, 0.7% of CareTrust REIT shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Sabra Healthcare REIT currently has a consensus price target of $22.20, indicating a potential upside of 5.21%. CareTrust REIT has a consensus price target of $42.82, indicating a potential upside of 1.00%. Given Sabra Healthcare REIT's higher possible upside, research analysts plainly believe Sabra Healthcare REIT is more favorable than CareTrust REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
CareTrust REIT
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
3 Strong Buy rating(s)
3.00

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.7%. CareTrust REIT pays an annual dividend of $1.34 per share and has a dividend yield of 3.2%. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CareTrust REIT pays out 85.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CareTrust REIT has raised its dividend for 3 consecutive years.

CareTrust REIT has lower revenue, but higher earnings than Sabra Healthcare REIT. CareTrust REIT is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.87$155.61M$0.6333.49
CareTrust REIT$476.39M21.02$320.54M$1.5627.18

CareTrust REIT has a net margin of 64.10% compared to Sabra Healthcare REIT's net margin of 19.22%. CareTrust REIT's return on equity of 8.65% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT19.22% 5.60% 2.84%
CareTrust REIT 64.10%8.65%6.66%

Summary

CareTrust REIT beats Sabra Healthcare REIT on 13 of the 20 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to LTC Properties?

Sabra Healthcare REIT (NASDAQ:SBRA) and LTC Properties (NYSE:LTC) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Sabra Healthcare REIT has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market. Comparatively, LTC Properties has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 69.3% of LTC Properties shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Comparatively, 2.2% of LTC Properties shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, LTC Properties had 9 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 17 mentions for LTC Properties and 8 mentions for Sabra Healthcare REIT. Sabra Healthcare REIT's average media sentiment score of 0.97 beat LTC Properties' score of 0.36 indicating that Sabra Healthcare REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
LTC Properties
4 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sabra Healthcare REIT presently has a consensus price target of $22.20, suggesting a potential upside of 5.21%. LTC Properties has a consensus price target of $40.40, suggesting a potential upside of 4.58%. Given Sabra Healthcare REIT's higher possible upside, equities research analysts clearly believe Sabra Healthcare REIT is more favorable than LTC Properties.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
LTC Properties
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.57

LTC Properties has a net margin of 38.99% compared to Sabra Healthcare REIT's net margin of 19.22%. LTC Properties' return on equity of 10.87% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT19.22% 5.60% 2.84%
LTC Properties 38.99%10.87%6.03%

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.7%. LTC Properties pays an annual dividend of $2.28 per share and has a dividend yield of 5.9%. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. LTC Properties pays out 92.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. LTC Properties is clearly the better dividend stock, given its higher yield and lower payout ratio.

Sabra Healthcare REIT has higher revenue and earnings than LTC Properties. LTC Properties is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.87$155.61M$0.6333.49
LTC Properties$262.85M7.52$117.97M$2.4715.64

Summary

LTC Properties beats Sabra Healthcare REIT on 11 of the 19 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to National Health Investors?

Sabra Healthcare REIT (NASDAQ:SBRA) and National Health Investors (NYSE:NHI) are both mid-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.7%. National Health Investors pays an annual dividend of $3.68 per share and has a dividend yield of 4.9%. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. National Health Investors pays out 118.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Sabra Healthcare REIT presently has a consensus price target of $22.20, suggesting a potential upside of 5.21%. National Health Investors has a consensus price target of $87.50, suggesting a potential upside of 16.68%. Given National Health Investors' stronger consensus rating and higher possible upside, analysts clearly believe National Health Investors is more favorable than Sabra Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
National Health Investors
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86

Sabra Healthcare REIT has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market. Comparatively, National Health Investors has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market.

National Health Investors has a net margin of 36.86% compared to Sabra Healthcare REIT's net margin of 19.22%. National Health Investors' return on equity of 9.82% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT19.22% 5.60% 2.84%
National Health Investors 36.86%9.82%5.35%

Sabra Healthcare REIT has higher revenue and earnings than National Health Investors. National Health Investors is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.87$155.61M$0.6333.49
National Health Investors$375.63M9.68$142.18M$3.1024.19

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 62.5% of National Health Investors shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Comparatively, 2.7% of National Health Investors shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Sabra Healthcare REIT had 6 more articles in the media than National Health Investors. MarketBeat recorded 8 mentions for Sabra Healthcare REIT and 2 mentions for National Health Investors. Sabra Healthcare REIT's average media sentiment score of 0.97 beat National Health Investors' score of 0.29 indicating that Sabra Healthcare REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
National Health Investors
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

National Health Investors beats Sabra Healthcare REIT on 10 of the 19 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to Omega Healthcare Investors?

Omega Healthcare Investors (NYSE:OHI) and Sabra Healthcare REIT (NASDAQ:SBRA) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 5.6%. Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.7%. Omega Healthcare Investors pays out 129.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Omega Healthcare Investors currently has a consensus price target of $48.83, suggesting a potential upside of 1.75%. Sabra Healthcare REIT has a consensus price target of $22.20, suggesting a potential upside of 5.21%. Given Sabra Healthcare REIT's stronger consensus rating and higher probable upside, analysts clearly believe Sabra Healthcare REIT is more favorable than Omega Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omega Healthcare Investors
1 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.43
Sabra Healthcare REIT
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

Omega Healthcare Investors has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, Sabra Healthcare REIT has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market.

Omega Healthcare Investors has a net margin of 51.14% compared to Sabra Healthcare REIT's net margin of 19.22%. Omega Healthcare Investors' return on equity of 11.86% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Omega Healthcare Investors51.14% 11.86% 6.10%
Sabra Healthcare REIT 19.22%5.60%2.84%

Omega Healthcare Investors has higher revenue and earnings than Sabra Healthcare REIT. Omega Healthcare Investors is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omega Healthcare Investors$1.19B12.01$572.03M$2.0723.19
Sabra Healthcare REIT$774.63M6.87$155.61M$0.6333.49

65.3% of Omega Healthcare Investors shares are owned by institutional investors. Comparatively, 99.4% of Sabra Healthcare REIT shares are owned by institutional investors. 1.5% of Omega Healthcare Investors shares are owned by insiders. Comparatively, 1.1% of Sabra Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Sabra Healthcare REIT had 4 more articles in the media than Omega Healthcare Investors. MarketBeat recorded 8 mentions for Sabra Healthcare REIT and 4 mentions for Omega Healthcare Investors. Omega Healthcare Investors' average media sentiment score of 0.98 beat Sabra Healthcare REIT's score of 0.97 indicating that Omega Healthcare Investors is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omega Healthcare Investors
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sabra Healthcare REIT
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Omega Healthcare Investors beats Sabra Healthcare REIT on 11 of the 18 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to Weyerhaeuser?

Weyerhaeuser (NYSE:WY) and Sabra Healthcare REIT (NASDAQ:SBRA) are both specialized reits companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

In the previous week, Weyerhaeuser had 1 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 9 mentions for Weyerhaeuser and 8 mentions for Sabra Healthcare REIT. Sabra Healthcare REIT's average media sentiment score of 0.97 beat Weyerhaeuser's score of 0.94 indicating that Sabra Healthcare REIT is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Weyerhaeuser
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sabra Healthcare REIT
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Weyerhaeuser has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, Sabra Healthcare REIT has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

Weyerhaeuser currently has a consensus price target of $28.50, suggesting a potential upside of 23.19%. Sabra Healthcare REIT has a consensus price target of $22.20, suggesting a potential upside of 5.21%. Given Weyerhaeuser's higher probable upside, research analysts plainly believe Weyerhaeuser is more favorable than Sabra Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Weyerhaeuser
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45
Sabra Healthcare REIT
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

Weyerhaeuser has higher revenue and earnings than Sabra Healthcare REIT. Sabra Healthcare REIT is trading at a lower price-to-earnings ratio than Weyerhaeuser, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Weyerhaeuser$6.91B2.42$324M$0.5442.84
Sabra Healthcare REIT$774.63M6.87$155.61M$0.6333.49

Sabra Healthcare REIT has a net margin of 19.22% compared to Weyerhaeuser's net margin of 5.78%. Sabra Healthcare REIT's return on equity of 5.60% beat Weyerhaeuser's return on equity.

Company Net Margins Return on Equity Return on Assets
Weyerhaeuser5.78% 1.45% 0.83%
Sabra Healthcare REIT 19.22%5.60%2.84%

Weyerhaeuser pays an annual dividend of $0.84 per share and has a dividend yield of 3.6%. Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.7%. Weyerhaeuser pays out 155.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sabra Healthcare REIT pays out 190.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Weyerhaeuser has raised its dividend for 3 consecutive years.

83.0% of Weyerhaeuser shares are owned by institutional investors. Comparatively, 99.4% of Sabra Healthcare REIT shares are owned by institutional investors. 0.3% of Weyerhaeuser shares are owned by company insiders. Comparatively, 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Sabra Healthcare REIT beats Weyerhaeuser on 10 of the 19 factors compared between the two stocks.

Get Sabra Healthcare REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBRA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBRA vs. The Competition

MetricSabra Healthcare REITREIT IndustryFinance SectorNASDAQ Exchange
Market Cap$5.29B$9.85B$13.49B$12.20B
Dividend Yield5.72%5.13%5.81%5.30%
P/E Ratio33.4946.8023.1425.58
Price / Sales6.875.22175.5578.84
Price / Cash15.2614.6520.5055.34
Price / Book1.912.062.146.66
Net Income$155.61M$222.69M$1.11B$333.63M
7 Day Performance2.53%-1.29%-1.14%-0.11%
1 Month Performance3.74%3.61%0.13%3.94%
1 Year Performance20.57%11.62%10.81%36.07%

Sabra Healthcare REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBRA
Sabra Healthcare REIT
2.3313 of 5 stars
$21.10
+0.6%
$22.20
+5.2%
+18.9%$5.29B$774.63M33.4940
CTRE
CareTrust REIT
3.6758 of 5 stars
$39.50
+0.8%
$42.82
+8.4%
N/A$8.75B$476.39M25.4820
LTC
LTC Properties
2.9175 of 5 stars
$38.25
-0.7%
$39.60
+3.5%
+9.0%$1.91B$262.85M15.6720
NHI
National Health Investors
3.6577 of 5 stars
$75.66
-1.4%
$87.50
+15.7%
+0.7%$3.72B$375.63M25.0520
OHI
Omega Healthcare Investors
2.6383 of 5 stars
$46.16
-1.8%
$48.67
+5.4%
+31.9%$13.99B$1.19B22.3050

Related Companies and Tools


This page (NASDAQ:SBRA) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners